Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS) Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2018
NCT03527732
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre Suisse de Recherches Scientifiques en Cote d'Ivoire | Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS) | Côte d'Ivoire: Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS)

Active Ingredients

Drugs in Phase 3 Trials (3)

albendazole (Albenza) (3 trials)

ivermectin (stromectol) (2 trials)

moxidectin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ancylostomiasis (Phase 2)

Hookworm Infections (Phase 2)

Trichuriasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3